Promoting and accelerating muscle regeneration through cell therapy in a mouse model

Area of Science:

• Biomedical research
• Regenerative medicine
• Cell therapy

Background:

• Skeletal muscle injuries present significant clinical challenges, leading to pain and disability.
• Stem cell therapy offers innovative solutions for musculoskeletal disorders by promoting tissue regeneration.

Purpose of the Study:

• To investigate mesenchymal stem cells (MSCs) and their differentiated myocytes for skeletal muscle regeneration.
• To evaluate cell-based therapy for damaged or diseased skeletal muscle.

Main Methods:

• Bone marrow mesenchymal stem cells (BM-MSCs) were isolated and characterized.
• BM-MSCs were differentiated into skeletal muscle cells in vitro over 7 days.
• Cell therapy efficacy was assessed in vivo using a mouse muscle injury model.

Main Results:

• BM-MSCs expressed specific surface markers (CD90, CD105) and lacked others (CD45, CD34).
• Differentiated myocytes showed confirmed skeletal muscle lineage via morphology and markers (Myf-6, MHC, desmin).
• Differentiated myocytes demonstrated superior muscle repair enhancement compared to undifferentiated BM-MSCs in vivo.

Conclusions:

• Myocytes derived from BM-MSCs hold promise for treating muscular atrophy and skeletal muscle injuries.
• This approach advances cell-based therapeutic strategies for musculoskeletal conditions.